Date: 2014-05-21
Type of information:
Acquired company: Keocyt (France)
Acquiring company: Riemser Pharma (Germany)
Amount: undisclosed
Terms: * On May 21,2014, Riemser Pharma announced takeover of Keocyt, a French pharmaceutical company, strengthening its international position in the specialty pharmaceutical sector. With this acquisition, Riemser reached another important milestone of its international growth strategy and significantly strengthens its position on the French and neighbouring Southern European markets.
Details: Keocyt brings to market pharmaceutical products that are applied in the treatment of rare diseases, especially in cancer therapy and neurology. The Paris based company was founded in 2007 by two former employees of Pfizer, Jean-Francois Auffret and Christophe Pasik. The company markets the drugs Zanosar®, Estracyt®, Prodilantin® and Dilantin® used for the treatment of certain pancreatic endocrine tumors, prostate cancer and status epilepticus, respectively.
Related: specialty pharmaceuticals
